Clinical Trial Update: Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary [Phase 3]

View source ↗

Summary

A phase 3 clinical trial compares cisplatin alone versus cisplatin plus gemcitabine in patients with carcinoma of unknown primary; the trial status is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma of Unknown Primary

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Carcinoma | Phase 3 | Status: UNKNOWN